Currently, there are 1.00B common shares owned by the public and among those 964.21M shares have been available to trade.
The company’s stock has a 5-day price change of 1.74% and -12.91% over the past three months. GM shares are trading -16.67% year to date (YTD), with the 12-month market performance up to 4.55% higher. It has a 12-month low price of $38.96 and touched a high of $61.24 over the same period. GM has an average intraday trading volume of 15.23 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.83%, -5.90%, and -9.49% respectively.
Institutional ownership of General Motors Company (NYSE: GM) shares accounts for 90.08% of the company’s 1.00B shares outstanding.
It has a market capitalization of $42.89B and a beta (3y monthly) value of 1.32. The stock’s trailing 12-month PE ratio is 7.23, while the earnings-per-share (ttm) stands at $6.14. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.18% over the week and 4.31% over the month.
Analysts forecast that General Motors Company (GM) will achieve an EPS of 2.65 for the current quarter, 3.01 for the next quarter and 11.04 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 2.17 while analysts give the company a high EPS estimate of 2.17. Comparatively, EPS for the current quarter was 2.62 a year ago. Earnings per share for the fiscal year are expected to increase by 2.76%, and -0.61% over the next financial year. EPS should shrink at an annualized rate of -1.06% over the next five years, compared to 6.84% over the past 5-year period.
Looking at the support for the GM, a number of firms have released research notes about the stock. Barclays stated their Equal Weight rating for the stock in a research note on April 15, 2025, with the firm’s price target at $40. Deutsche Bank coverage for the General Motors Company (GM) stock in a research note released on April 14, 2025 offered a Hold rating with a price target of $43. UBS was of a view on April 10, 2025 that the stock is Neutral, while Bernstein gave the stock Underperform rating on April 07, 2025, issuing a price target of $35. JP Morgan on their part issued Overweight rating on March 27, 2025.
